BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Meng W, Zhu HH, Xu ZF, Cai SR, Dong Q, Pan QR, Zheng S, Zhang SZ. Serum M2-pyruvate kinase: A promising non-invasive biomarker for colorectal cancer mass screening. World J Gastrointest Oncol 2012; 4(6): 145-151 [PMID: 22737276 DOI: 10.4251/wjgo.v4.i6.145]
URL: https://www.wjgnet.com/1007-9327/full/v4/i6/145.htm
Number Citing Articles
1
Philip D. Hardt. Tumor Cell Metabolism2015; : 165 doi: 10.1007/978-3-7091-1824-5_8
2
Zeinab Deris Zayeri, Abazar Parsi, Saeid Shahrabi, Masoud Kargar, Nader Davari, Najmaldin Saki. Epigenetic and metabolic reprogramming in inflammatory bowel diseases: diagnostic and prognostic biomarkers in colorectal cancerCancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-03117-z
3
Zongwei Li, Peng Yang, Zhuoyu Li. The multifaceted regulation and functions of PKM2 in tumor progressionBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2014; 1846(2): 285 doi: 10.1016/j.bbcan.2014.07.008
4
Adrien Grancher, Steven Cuissy, Hélène Girot, André Gillibert, Frédéric Di Fiore, Lydia Guittet. Where do we stand with screening for colorectal cancer and advanced adenoma based on serum protein biomarkers? A systematic reviewMolecular Oncology 2024;  doi: 10.1002/1878-0261.13734
5
Antonio Mestrovic, Nikola Perkovic, Dorotea Bozic, Marko Kumric, Marino Vilovic, Josko Bozic. Precision Medicine in Inflammatory Bowel Disease: A Spotlight on Emerging Molecular BiomarkersBiomedicines 2024; 12(7): 1520 doi: 10.3390/biomedicines12071520
6
Mallikarjuna Uppara, Franklin Adaba, Alan Askari, Susan Clark, George Hanna, Thanos Athanasiou, Omar Faiz. A systematic review and meta-analysis of the diagnostic accuracy of pyruvate kinase M2 isoenzymatic assay in diagnosing colorectal cancerWorld Journal of Surgical Oncology 2015; 13(1): 48 doi: 10.1186/s12957-015-0446-4
7
Yifan Zhu, Lisheng Wang, Yanying Nong, Yunxiao Liang, Zongsheng Huang, Pingchuan Zhu, Qisong Zhang. Serum Untargeted UHPLC-HRMS-Based Lipidomics to Discover the Potential Biomarker of Colorectal Advanced AdenomaCancer Management and Research 2021; : 8865 doi: 10.2147/CMAR.S336322
8
Farhadul Islam. Current Cancer Biomarkers2023; : 180 doi: 10.2174/9789815079364123010012
9
Paul Dowling, David J. Hughes, Anne Marie Larkin, Justine Meiller, Michael Henry, Paula Meleady, Vincent Lynch, Barbara Pardini, Alessio Naccarati, Miroslav Levy, Pavel Vodicka, Paul Neary, Martin Clynes. Elevated levels of 14-3-3 proteins, serotonin, gamma enolase and pyruvate kinase identified in clinical samples from patients diagnosed with colorectal cancerClinica Chimica Acta 2015; 441: 133 doi: 10.1016/j.cca.2014.12.005
10
Hisham K. Dabbous, Yosry Abd El-Rahman Mohamed, Runia F. El-Folly, Mohamed D. El-Talkawy, Hani E. Seddik, Dina Johar, Mohammed A. Sarhan. Evaluation of Fecal M2PK as a Diagnostic Marker in Colorectal CancerJournal of Gastrointestinal Cancer 2019; 50(3): 442 doi: 10.1007/s12029-018-0088-1
11
M V Kruchinina, A A Gromov, Y I Prudnikova, V M Generalov, V N Kruchinin, V A Volodin, G V Shuvalov, O V Minin, S V Shehovtsov, S E Peltec, I V Minin. Application of ellipsometry, spr-technic and raman-spectroscopy into diagnosis of colorectal cancerIOP Conference Series: Materials Science and Engineering 2019; 516: 012017 doi: 10.1088/1757-899X/516/1/012017
12
Idil Esen, William F Jiemy, Yannick van Sleen, Johan Bijzet, Daniel M de Jong, Pieter H Nienhuis, Riemer H J A Slart, Peter Heeringa, Annemieke M H Boots, Elisabeth Brouwer. Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritisRheumatology 2022; 61(7): 3060 doi: 10.1093/rheumatology/keab814
13
Abdo Alnabulsi, Graeme I. Murray. Proteomics for early detection of colorectal cancer: recent updatesExpert Review of Proteomics 2018; 15(1): 55 doi: 10.1080/14789450.2018.1396893
14
Hongwei Chen, Hailin Zhou, Yunxiao Liang, Zongsheng Huang, Shanyi Yang, Xuancheng Wang, Zhiyong She, Zhijuan Wei, Qisong Zhang. UHPLC-HRMS-based serum untargeted lipidomics: Phosphatidylcholines and sphingomyelins are the main disturbed lipid markers to distinguish colorectal advanced adenoma from cancerJournal of Pharmaceutical and Biomedical Analysis 2023; 234: 115582 doi: 10.1016/j.jpba.2023.115582
15
Ze Qian, Wendi Hu, Zhen Lv, Hua Liu, Diyu Chen, Yacong Wang, Jian Wu, Shusen Zheng. PKM2 upregulation promotes malignancy and indicates poor prognosis for intrahepatic cholangiocarcinomaClinics and Research in Hepatology and Gastroenterology 2020; 44(2): 162 doi: 10.1016/j.clinre.2019.06.008
16
Paige Druce, Natalia Calanzani, Claudia Snudden, Kristi Milley, Rachel Boscott, Dawnya Behiyat, Javiera Martinez-Gutierrez, Smiji Saji, Jasmeen Oberoi, Garth Funston, Mike Messenger, Fiona M. Walter, Jon Emery. Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Lower Gastrointestinal Cancers: A Systematic Review and Meta-AnalysisAdvances in Therapy 2021; 38(6): 3032 doi: 10.1007/s12325-021-01645-6
17
Amir Hossein Aalami, Ali Shahriari, Mohammad Mazaheri, Farnoosh Aalami, Amir Amirabadi, Amirhossein Sahebkar. Diagnostic accuracy of tumor M2-pyruvate kinase (tM2-PK) as a non-invasive biomarker in colorectal cancer: A systematic review and meta-analysisClinical Biochemistry 2023; 120: 110652 doi: 10.1016/j.clinbiochem.2023.110652
18
V. N. Kruchinin, M. V. Kruchinina, Ya. I. Prudnikova, E. V. Spesivtsev, S. V. Rykhlitskii, V. A. Volodin, S. V. Shekhovtsov, S. E. Pel’tek. The Use of Spectral Ellipsometry and Raman Spectroscopy in Screening Diagnostics of Colorectal CancerOptics and Spectroscopy 2019; 127(1): 170 doi: 10.1134/S0030400X19070142
19
Mahmood Khosravi, Ali Arash Anoushirvani, Zahedin Kheiri, Ali Rahbari, Ali Jadidi. The Importance of Evaluating Serum Levels of Tumor Markers M2-PK and Inhibin A in Patients Undergoing ColonoscopyTechnology in Cancer Research & Treatment 2023; 22 doi: 10.1177/15330338231194492
20
Paul Dowling, Damian Pollard, AnneMarie Larkin, Michael Henry, Paula Meleady, Kathy Gately, Kenneth O'Byrne, Martin P. Barr, Vincent Lynch, Jo Ballot, John Crown, Michael Moriarty, Emmet O'Brien, Ross Morgan, Martin Clynes. Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancerMolecular BioSystems 2015; 11(3): 743 doi: 10.1039/C4MB00384E
21
Yan-Jun Liu, Shu Zhang, Kang Hou, Yun-Tao Li, Zhan Liu, Hai-Liang Ren, Dan Luo, Shi-Hong Li. Analysis of Key Genes and Pathways Associated with Colorectal Cancer with Microarray TechnologyAsian Pacific Journal of Cancer Prevention 2013; 14(3): 1819 doi: 10.7314/APJCP.2013.14.3.1819